Could Zepid be viable in domestic anti-impotence drug market?

The Korea Food and Drug Administration (KFDA) recently approved the domestic sale of Zepid, a new type of anti-impotency drug.

Created by JW Pharmaceutical, Zepid is expected to be launched in the last quarter of this year, but concerns are mounting over its viability in the domestic erectile dysfunction drugs market dominated by three big markers.

Pfizer’s Viagra, the world’s first devel...